CORRIGENDUM FOR “High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance”

The Journal of Clinical Endocrinology & Metabolism, May 2018

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://academic.oup.com/jcem/article-pdf/103/5/2074/24795245/jc.2018-00530.pdf

CORRIGENDUM FOR “High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance”

In the above-named article by Kim HI, Jang HW, Ahn HS, Ahn S, Park SY, Oh YL, Hahn SY, Shin JH, Kim J-H, Kim JS, Chung JH, Kim TH, and Kim SW (J Clin Endocrinol Metab. CORRIGENDUM FOR “High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance” “Age ,55 at diagnosis was also a prognostic factor for PTMC progression (HR 0.26; 95% CI, 0.07 to 0.88; P 5 0.031) in univariate analysis, although the P value in multivariate analysis did not reach statistical significance (HR 0.29; 95% CI, 0.08 to 1.01; P 5 0.052) (Table 3).” “Age $55 at diagnosis was also a prognostic factor for PTMC progression (HR 0.26; 95% CI, 0.07 to 0.88; P 5 0.031) in univariate analysis, although the P value in multivariate analysis did not reach statistical significance (HR 0.29; 95% CI, 0.08 to 1.01; P 5 0.052) (Table 3).” - https://academic.oup.com/jcem


This is a preview of a remote PDF: https://academic.oup.com/jcem/article-pdf/103/5/2074/24795245/jc.2018-00530.pdf

CORRIGENDUM FOR “High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance”, The Journal of Clinical Endocrinology & Metabolism, 2018, 2074, DOI: 10.1210/jc.2018-00530